menieres drug trial

Sound Pharmaceuticals Announces Encouraging Results in Meniere’s Disease Clinical Trial; May Go Public in 2020

SEATTLE, WASHINGTON — Biotech firm, Sound Pharmaceuticals, announced positive top-line results from a randomized, double-blind, placebo-controlled, multi-center Phase 2b study in Meniere’s Disease (MD).   Evaluating SPI-1005 vs. Placebo in Meniere’s Patients   In the study, 149 adult patients with active MD, including a hearing loss at baseline of >30 dB in one of three…

Read More
sensorion hearing loss

Sensorion Receives FDA Investigational New Drug Clearance for Arazasetron (SENS-401)

MONTPELLIER, FRANCE — French biotech firm Sensorion, which specializes in the development of novel therapies to restore, treat and prevent inner ear diseases such as hearing loss, tinnitus and vertigo, announced today that it has received the Investigational New Drug (IND) clearance from the US Food and Drug Administration (FDA) to proceed with SENS-401, based on…

Read More
vestibular hair cell regeneration

Researchers Regenerate Hair Cells in Vestibular System of Mice

Researchers at the Stanford University School of Medicine have found a way to regenerate hair cells in the inner ears of mice, allowing the animals to recover vestibular function. This is the first time such recovery has been observed in mature mammals. The research was published recently published on July 9 in Cell Reports. According to the…

Read More
american tinnitus association

American Tinnitus Association Adds Five New Members to Board of Directors

VIENNA, VIRGINIA — The American Tinnitus Association (ATA) has elected five members to serve three-year terms on its board of directors, according to Dr. Jill Meltzer, newly elected ATA Board Chair.  “Our new board members bring experience with tinnitus, research, business, and non-profit organizations to ATA, and we will benefit greatly from their expertise and…

Read More
counseling hearing loss cognitive decline

Articles Offer Insights on Discussing Hearing Loss and Cognitive Decline with Patients

By Brian Taylor, AuD, Editor-at-Large The relationship between hearing loss and cognitive ability has received considerable attention in the academic literature and professional publications over the past several years and for good reason. Both conditions are harmful, and because of the rapidly aging population becoming more prevalent and are likely, without improved intervention strategies, to…

Read More
samsung nuheara acquisition

Samsung Subsidiary Launched Failed $84M Takeover Bid for Nuheara: Report

According to a new report in the Australian Financial Review, consumer electronics giant Samsung recently launched a takeover bid for Australian audio device maker, Nuheara. However, according to the original report, the company pulled its offer after discovering that the disclosure documents had to be submitted to the Australian Securities Exchange (ASX). Nuheara reportedly went…

Read More
decibel therapeutics

Healthcare Industry Veteran, Christine Poon, Appointed to Decibel Therapeutics Board of Directors

BOSTON, MASSACHUSETTS — Biotech startup, Decibel Therapeutics, has announced the appointment of Christine Poon to its board of directors. Ms. Poon has spent more than 30 years in leadership roles in the biopharmaceutical industry. She currently serves as executive in residence of The Max M. Fisher College of Business at The Ohio State University, having…

Read More
cochlea 3d imaging

Advanced 3D Imaging of Ear Anatomy to Assist in Cochlear Implant Design and Placement

Using advanced techniques, researchers at the at the University of Saskatchewan have created three-dimensional images of the complex interior anatomy of the human ear, information that is key to improving the design and placement of cochlear implants. “With the images, we can now see the relationship between the cochlear implant electrode and the soft tissue,…

Read More